Prognostic Testing

Prognostic tests can help you and your healthcare provider understand the biology of your tumor by looking at the level of expression in certain genes.

This is the basis for Myriad’s Prolaris® testing as well as a number of additional tests Myriad has in development for lung, bladder and kidney cancers. The goal with these prognostic tests is to better predict disease outcome, thereby optimizing treatment and decision making.